DK419;inhibit,DK419,Wnt,β-catenin,Inhibitor,DK 419,Beta catenin,DK-419;1H-Benzimidazole-7-carboxamide, 5-chloro-2-(trifluoromethyl)-N-[4-(trifluoromethyl)phenyl]-;DK419, 10 mM in DMSO
DK419 is a potent, orally available inhibitor of the Wnt/β-catenin signaling pathway; it downregulates Axin2, β-catenin, c-Myc, Cyclin D1, and Survivin, alters cellular oxygen consumption rate, and induces pAMPK production.